Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Hb F modulates sickle cell disease. Five major haplotypes of the β-globin gene cluster are associated with sickle cell disease. In the Eastern Province of Saudi Arabia, the Arab-Indian (AI) is most common. Single nucleotide polymorphism (SNP) genotyping (rs3834466, rs28440105, rs10128556, and rs968857) was carried out by nuclease allelic discrimination assay with target-specific forward and reverse primers, TaqMan probes, labeled with VIC and FAM. In 778 patients with sickle cell disease from the Eastern Province, a haplotype was assigned to 90.9% of all samples; 9.1% were classified as compound heterozygotes for the AI and an atypical haplotype. The distribution of haplotypes for 746 Hb S (HBB: c.20A > T) homozygotes was: 614 AI/AI, nine SEN/SEN (Senegal), 42 SEN/AI, nine CAM/CAM (Cameroon), one CAR (Central African Republic)/BEN (Benin), 71 AI/atypical. In Hb S/β-thalassemia (Hb S/β-thal), the distribution of Hb S haplotypes was: 22 AI/AI, one CAM/CAM, four AI/SEN, five AI/atypical. Mean Hb F in the haplotypes was: AI/AI 16.6 ± 7.5%, CAM/CAM 8.0 ± 4.1%, SEN/SEN 11.0 ± 5.1%, SEN/AI 15.1 ± 4.6%, AI/atypical 16.2 ± 6.5%. The presence of the SEN and CAM haplotypes was unexpected due to the apparent homogeneity of the population of the Eastern Province. We have successfully classified sickle cell disease haplotypes using the relatively inexpensive TaqMan assay for the first time. In addition, we have previously shown that children with AI haplotype have Hb F of 30.0% and mild disease, while in our cohort of adult AI patients, which might be the largest yet reported, Hb F was about 16.6%.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adult HbS homozygotes with the AI haplotype have a mean baseline HbF of 17% 35 ; Senegal haplotype patients have HbF of ;10%.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [35]
In the citing paper
“Saudi patients with Bantu and Cameroon haplotypes have HbF of ;8% compared with ;5% in their African counterparts.35”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [35]
Citations
Cites
Piel, F. B., Hay, S. I., Gupta, S., Weatherall, D. J., & Williams, T. N. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001484 · Cited by 1,138
Fetal hemoglobin in sickle cell anemia
Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., Chui, D. H. K., & Steinberg, M. H. (2011) · Blood · doi:10.1182/blood-2011-03-325258 · Cited by 553
Self-citationGenetic modifiers of sickle cell disease
Steinberg, M. H., & Sebastiani, P. (2012) · American Journal of Hematology · doi:10.1002/ajh.23232 · Cited by 315 · cited 1×
“The major modulator of the severity of the disease is the level of Hb F (a2a2) [2,3].”
BackgroundSelf-citationSutton, M., Bouhassira, E. E., & Nagel, R. L. (1989) · American Journal of Hematology · doi:10.1002/ajh.2830320113 · Cited by 306
Galarneau, G., Palmer, C. D., Sankaran, V. G., Orkin, S. H., Hirschhorn, J. N., & Lettre, G. (2010) · Nature Genetics · doi:10.1038/ng.707 · Cited by 269
Fetal hemoglobin in sickle cell anemia: a glass half full?
Steinberg, M. H., Chui, D. H. K., Dover, G. J., Sebastiani, P., & Alsultan, A. (2014) · Blood · doi:10.1182/blood-2013-09-528067 · Cited by 267 · cited 1×
“rocytes not containing sufficient Hb F to protect them from polymer-induced damage [27].”
BackgroundSelf-citationNagel, R. L., Fabry, M. E., Pagnier, J., Zohoun, I., Wajcman, H., Baudin, V., & Labie, D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121403 · Cited by 263
Perrine, R. P., Brown, M. J., Clegg, J. B., Weatherall, D. J., & May, A. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92592-5 · Cited by 220 · cited 1×
“Generally, patients with a higher Hb F level have milder disease than those with lower Hb F [6,7].”
BackgroundIndividual variation in the production and survival of F cells in sickle-cell disease
Dover, G. J., Boyer, S. H., Charache, S., & Heintzelman, K. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812282992603 · Cited by 144 · cited 1×
“Hb F levels are heritable; they vary in and within the sickle cell disease populations [4,5].”
BackgroundShriner, D., & Rotimi, C. N. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.02.003 · Cited by 118 · cited 1×
“This haplotype was related to the CAR, CAM, and AI haplotypes from which were derived the SEN and BEN haplotypes [14,15].”
Method
Research works printed but not linked: 2
- Kazazian HH, 1983, Prog Clin Biol Res, 134, 91
- Miri-Moghaddam E, 2017, Int J Hematol Oncol Stem Cell Res, 11, 165
Cited by
Fetal hemoglobin in sickle cell anemia
Steinberg, M. H. (2020) · Blood · doi:10.1182/blood.2020007645 · Cited by 136
Self-citationFetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes
Steinberg, M. H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113782 · Cited by 89
Self-citationGenetic epidemiology of hemoglobinopathies among Iraqi Kurds
Al-Allawi, N. A. S., Allawi, S. A., & Jalal, S. D. (2020) · Journal of Community Genetics · doi:10.1007/s12687-020-00495-z · Cited by 41
Sickle cell disease in the Eastern Province of Saudi Arabia: Clinical and laboratory features
Al‐Ali, A. K., Alsulaiman, A., Alfarhan, M. F. A., Safaya, S., Vatte, C., Albuali, W. H., Qutub, H. O., Alzahrani, A. J., Milton, J. N., & Steinberg, M. H. (2021) · American Journal of Hematology · doi:10.1002/ajh.26096 · Cited by 20
Self-citationTargeting fetal hemoglobin expression to treat β hemoglobinopathies
Steinberg, M. H. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2066519 · Cited by 19
Self-citation
Metadata
- Authors
- Al-Ali, A. K., Alsulaiman, A., Alzahrani, A. J., Obeid, O. T., Vatte, C. B., Cyrus, C., Alnafie, A. N., Alali, R. A., Alfarhan, M., Mozeleski, B., & Steinberg, M. H.
- Affiliations
- Department of Clinical Biochemistry, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia;
- King Faisal University (SA)
- University of Hafr Al-Batin (SA)
- Imam Abdulrahman Bin Faisal University (SA)
- Department of Pathology, King Fahd Hospital of The University, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia;
- King Fahd Hospital of the University (SA)
- Boston Medical Center (US)
- Venue
- Hemoglobin
- Publisher
- Informa UK Limited
- Published
- 2020-03-03
- Volume
- 44
- Issue
- 2
- Pages
- 78-81
- ISSN
- 0363-0269 (ISSN-L)
- 1532-432X
- OpenAlex
- W3027017062
- Semantic Scholar
- 6562a1db6421cc82bade1b88eb7b75db68f22fa9
- Cited by
- 20
- References
- 27
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 6 · 2021: 4 · 2020: 5
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hemoglobin (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, fetal hemoglobin, beta-thalassemia, haplotype diversity, compound heterozygosity, TaqMan genotyping, Eastern Province, Saudi Arabia
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Anemia, Sickle Cell, Child, Child, Preschool, Female, Haplotypes, Hemoglobin, Sickle, Humans, Male, Middle Aged, Saudi Arabia, Prevalence, Polymorphism, Single Nucleotide, beta-Globins, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia. https://app.cochat.ai/papers/10.1080/03630269.2020.1739068
- The paper
- Al-Ali, A. K., Alsulaiman, A., Alzahrani, A. J., Obeid, O. T., Vatte, C. B., Cyrus, C., Alnafie, A. N., Alali, R. A., Alfarhan, M., Mozeleski, B., & Steinberg, M. H. (2020). Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia. Hemoglobin. https://doi.org/10.1080/03630269.2020.1739068
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.